Maimon Carole Ben - President and CEO, Director at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
LRMR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Maimon Carole Ben since 4/22/2024

Holdings reported by Maimon Carole Ben for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 387K $3.38M $8.74 Jan 22, 2025 Direct
Common Stock 12.2K $107K $8.74 Jan 22, 2025 By Trust
Stock Option (Right to Buy) 546K Jan 22, 2025 Direct Common Stock

Transactions reported by Maimon Carole Ben for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.